Harrow is a pharmaceutical company concentrating on ophthalmic therapies. The company actively develops and commercializes both compounded and FDA-approved medications for various eye conditions. Harrow digital transformation focuses on streamlining patient access to medications, automating critical manufacturing processes, and digitizing its commercial operations to improve market reach. This approach emphasizes direct distribution channels and technology-driven solutions to enhance affordability and accessibility of their product portfolio.
This ongoing transformation creates dependencies on robust digital systems and integrated data workflows across the organization. The reliance on new platforms for patient interaction and manufacturing control introduces specific operational challenges and potential system breakdowns. This page analyzes Harrow’s key digital transformation initiatives, the critical control points where execution becomes difficult, and where sellers can engage effectively.
Harrow Snapshot
Headquarters: Nashville, United States
Number of employees: 373 employees
Public or private: Public
Business model: B2B
Website: http://www.harrow.com
Harrow ICP and Buying Roles
Harrow sells to pharmaceutical distribution networks and institutional healthcare providers. The company also sells to specialized ophthalmology practices and eye care professionals directly.
Who drives buying decisions
- Chief Commercial Officer → Oversees sales strategies and market expansion.
- VP of Sales → Manages field force deployment and commercial execution.
- Chief Scientific Officer → Directs research and development pipelines.
- Head of Manufacturing Operations → Manages production facilities and automation initiatives.
- Head of Market Access → Develops patient access programs and reimbursement strategies.
Key Digital Transformation Initiatives at Harrow (At a Glance)
- Deploying an online patient access portal across ophthalmology.
- Integrating advanced robotics into pharmaceutical production lines.
- Digitizing clinical trial data management for new drug candidates.
- Equipping sales teams with prescription tracking and analytics tools.
- Automating prior authorization workflows for medication access programs.
- Standardizing supply chain data for direct-to-physician distribution.
Where Harrow’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Patient Access & Hub Services Platforms | Patient Access Platform Deployment: manual data entry is required for patient enrollment into affordability programs. | Head of Market Access, Chief Commercial Officer | Validate patient eligibility against insurance data. |
| Patient Access Platform Deployment: prior authorization requests fail to sync with EHR systems. | Head of Market Access, VP of Sales | Route prior authorization data directly from EHR to access platforms. | |
| Patient Access Platform Deployment: patient support inquiries do not route to correct care representatives. | Head of Commercial Operations, Customer Service Director | Standardize inquiry routing based on patient program status. | |
| Pharmaceutical Manufacturing Automation | Pharmaceutical Production Automation: batch records require manual approval before release to packaging. | Head of Manufacturing Operations, Head of Quality Assurance | Enforce automated approval gates based on production parameters. |
| Pharmaceutical Production Automation: equipment calibration data does not propagate to quality control systems. | Head of Quality Assurance, Plant Manager | Detect discrepancies between equipment readings and quality checks. | |
| Pharmaceutical Production Automation: inventory levels for raw materials create production delays. | Supply Chain Director, Head of Manufacturing Operations | Detect stockouts and trigger reorder processes automatically. | |
| Clinical Trial & R&D Data Platforms | Clinical Development Data Orchestration: clinical trial data requires manual aggregation from multiple site sources. | Chief Scientific Officer, Head of R&D | Standardize data ingestion from diverse clinical trial systems. |
| Clinical Development Data Orchestration: regulatory submission documents contain inconsistent data points. | Chief Scientific Officer, Head of Regulatory Affairs | Validate data consistency across regulatory submission modules. | |
| Clinical Development Data Orchestration: research insights from various studies remain siloed. | Chief Scientific Officer, VP of Research | Consolidate research findings into a central knowledge repository. | |
| Commercial Operations Enablement | Commercial Field Operations Digitization: sales territories lack real-time prescription volume data for optimal targeting. | VP of Sales, Head of Commercial Operations | Route territory updates based on dynamic prescription data. |
| Commercial Field Operations Digitization: physician engagement data does not integrate with CRM for follow-up. | VP of Sales, Marketing Director | Validate CRM data against field activity for complete physician profiles. | |
| Commercial Field Operations Digitization: marketing content for specific products fails to reach relevant HCP segments. | Marketing Director, Chief Commercial Officer | Enforce content delivery to physician segments based on prescribing patterns. |
Identify when companies like Harrow are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Harrow’s digital transformation unique
Harrow’s digital transformation prioritizes making ophthalmic medications accessible and affordable through technology platforms. Unlike many pharmaceutical companies, Harrow balances branded product commercialization with a strong compounding business and direct-to-physician distribution. This creates a unique focus on integrating complex patient access programs with its supply chain and commercial activities. The company heavily depends on robust integrations to connect patient-facing portals with backend manufacturing and distribution systems.
Harrow’s Digital Transformation: Operational Breakdown
DT Initiative 1: Patient Access Platform Deployment
What the company is doing
Harrow is building a unified online portal, Harrow Access for All (HAFA), for prescribers and patients. This platform streamlines prescription processes and manages affordability programs for ophthalmic medications. It integrates with existing healthcare technology platforms to expand medication availability.
Who owns this
- Head of Market Access
- Chief Commercial Officer
- VP of Sales
Where It Fails
- Prior authorization requests require manual data entry between EHR and access platforms.
- Patient affordability program enrollment data fails to sync with pharmacy fulfillment systems.
- Prescription tracking information does not update across patient and prescriber portals.
- Patient support inquiries do not route to correct care representatives based on program status.
Talk track
Noticed Harrow is deploying patient access platforms for ophthalmic medications. Been looking at how some pharmaceutical companies are automating prior authorization data exchange instead of manual entry, can share what’s working if useful.
DT Initiative 2: Pharmaceutical Production Automation
What the company is doing
Harrow integrates advanced automation and robotics within its manufacturing facilities. This involves using automated control systems for drug formulation and efficient batch processing. The company maintains a state-of-the-art facility for pharmaceutical production and distribution.
Who owns this
- Head of Manufacturing Operations
- Head of Quality Assurance
- Supply Chain Director
Where It Fails
- Batch records require manual validation against production parameters.
- Equipment calibration data does not propagate to quality control systems.
- Inventory levels for raw materials create production delays in the manufacturing system.
- Production scheduling software does not account for real-time equipment maintenance status.
Talk track
Saw Harrow integrating robotics into pharmaceutical production. Been looking at how some manufacturing teams are enforcing automated batch record approvals instead of manual sign-offs, happy to share what we’re seeing.
DT Initiative 3: Clinical Development Data Orchestration
What the company is doing
Harrow is implementing systems to manage clinical trial data and regulatory submissions for new ophthalmic therapies. This includes progressing drug candidates through phases of development and expanding existing product labels. The company focuses on analyzing data for pipeline advancement.
Who owns this
- Chief Scientific Officer
- Head of R&D
- Head of Regulatory Affairs
Where It Fails
- Clinical trial data requires manual aggregation from multiple site sources.
- Regulatory submission documents contain inconsistent data points across different modules.
- Investigator-initiated study data does not integrate with central R&D platforms.
- Drug safety monitoring systems show delays in flagging adverse events from trials.
Talk track
Looks like Harrow is advancing its R&D pipeline with new drug candidates. Been seeing teams standardize clinical trial data ingestion instead of manual compilation, can share what’s working if useful.
DT Initiative 4: Commercial Field Operations Digitization
What the company is doing
Harrow equips its specialized sales forces with digital tools for territory management and prescription tracking. This involves enhancing commercial reach for products like VEVYE and TRIESENCE. The company uses data to optimize sales strategies and physician engagement.
Who owns this
- VP of Sales
- Head of Commercial Operations
- Marketing Director
Where It Fails
- Sales territories lack real-time prescription volume data for optimal targeting.
- Physician engagement data does not integrate with CRM for personalized follow-up.
- Marketing content for specific products fails to reach relevant HCP segments.
- Sales performance dashboards display inconsistent data due to manual data inputs.
Talk track
Seems like Harrow is digitizing its commercial field operations. Been looking at how some pharmaceutical sales teams are routing territory updates based on dynamic prescription data instead of static assignments, happy to share what we’re seeing.
Who Should Target Harrow Right Now
This account is relevant for:
- Patient access and affordability platform providers
- Pharmaceutical manufacturing automation systems
- Clinical trial data management platforms
- Sales force enablement and CRM solutions for pharma
- Regulatory information management systems
- Supply chain visibility and optimization platforms
Not a fit for:
- Basic website builders with no integration capabilities
- Standalone marketing tools without system connectivity
- Products designed for small, low-complexity teams
- Generic IT infrastructure providers without healthcare specialization
When Harrow Is Worth Prioritizing
Prioritize if:
- You sell solutions that validate patient eligibility against complex insurance rules for medication access.
- You sell platforms that route prior authorization data directly from EHR to access portals.
- You sell systems that enforce automated approval gates for pharmaceutical batch records.
- You sell solutions that detect discrepancies between equipment calibration and quality control systems.
- You sell platforms that standardize clinical trial data ingestion from diverse sources.
- You sell tools that validate data consistency across regulatory submission modules.
- You sell solutions that route sales territory updates based on dynamic prescription volume data.
- You sell platforms that integrate physician engagement data directly into CRM systems.
Deprioritize if:
- Your solution does not address any of the breakdowns identified in Harrow’s digital transformation.
- Your product is limited to basic functionality with no integration capabilities into pharmaceutical systems.
- Your offering is not built for multi-team or multi-system environments within a pharmaceutical context.
- Your solution requires significant manual configuration for each workflow step.
Who Can Sell to Harrow Right Now
Patient Access and Reimbursement Platforms
PhilRx - This company offers a patient access platform providing end-to-end visibility into the prescription lifecycle, simplifying prior authorizations.
Why they are relevant: Harrow's Patient Access Platform Deployment requires efficient handling of prior authorizations. PhilRx can automate prior authorization request submissions, reducing manual effort and improving prescription fulfillment rates.
PARx Solutions - This company provides a web-based technology stack to help prescribers overcome challenges with prior authorizations.
Why they are relevant: Harrow's Patient Access Platform Deployment experiences delays when prior authorization processes are manual. PARx Solutions can streamline prior authorization workflows, ensuring patients receive prescribed medications without administrative hurdles.
Manufacturing Execution Systems (MES)
Rockwell Automation (PharmaSuite MES) - This company provides MES software for plantwide production management in pharmaceutical manufacturing.
Why they are relevant: Harrow's Pharmaceutical Production Automation needs precise batch control and quality adherence. PharmaSuite MES can enforce automated approval gates for batch records and ensure data propagation to quality control systems.
Siemens (SIMATIC PCS 7) - This company offers a distributed control system (DCS) for process automation in industries including pharmaceuticals.
Why they are relevant: Harrow's Pharmaceutical Production Automation experiences delays from manual validation of production parameters. SIMATIC PCS 7 can provide integrated control, ensuring real-time data flow and automated process execution within manufacturing.
Clinical Data Management Systems
Veeva Systems (Veeva Vault Clinical Suite) - This company offers a comprehensive cloud-based suite for clinical operations and data management.
Why they are relevant: Harrow's Clinical Development Data Orchestration struggles with manual aggregation of clinical trial data. Veeva Vault Clinical Suite can standardize data ingestion from multiple trial sites and manage regulatory submission documents.
Medidata Solutions (Medidata Rave Clinical Cloud) - This company provides an integrated platform for clinical trial planning, execution, and data management.
Why they are relevant: Harrow's Clinical Development Data Orchestration faces inconsistencies in regulatory submission data. Medidata Rave Clinical Cloud can validate data points across study modules and streamline the regulatory submission process.
Sales Force Enablement for Pharma
Veeva Systems (Veeva CRM) - This company offers a customer relationship management solution specifically designed for the pharmaceutical industry.
Why they are relevant: Harrow's Commercial Field Operations Digitization lacks real-time prescription data for sales territories. Veeva CRM can integrate prescription volume data, enabling optimal targeting and personalized physician engagement.
IQVIA (Orchestrated Commercial Model) - This company provides integrated commercial solutions including sales force effectiveness and analytics.
Why they are relevant: Harrow's Commercial Field Operations Digitization faces issues with physician engagement data integration. IQVIA's solutions can connect physician engagement data with CRM, improving follow-up and content delivery to relevant segments.
Final Take
Harrow is scaling its digital patient access initiatives and automating pharmaceutical production. Breakdowns are visible in manual data transfers for patient programs, inconsistent data propagation in manufacturing, and fragmented data across commercial operations. This account is a strong fit for solutions that enforce data consistency and automate complex workflows within specialized pharmaceutical and healthcare access systems.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.